Literature DB >> 1971659

64,000 Mr autoantibodies as predictors of insulin-dependent diabetes.

M A Atkinson1, N K Maclaren, D W Scharp, P E Lacy, W J Riley.   

Abstract

The occurrence of autoantibodies to an islet-cell protein of 64,000 Mr (64KA) was examined in relation to development of insulin-dependent diabetes. 64KA were absent in 26 normal controls and present in only 1 of 41 first-degree relatives who lacked islet-cell cytoplasmic autoantibodies (ICA) or insulin autoantibodies (IAA). Among first-degree relatives at high risk for IDD, 64KA were identified in 23 of 28 persons positive for ICA and 4 of 5 with IAA but no ICA. Among 31 patients with newly diagnosed IDD, 64KA were found in 26. 64KA were identified in 23 of 28 persons studied up to 75 months before clinical onset of IDD. Of these 23 64KA-positive prediabetic subjects, 5 were ICA-negative and 10 lacked IAA. 64KA were most predictive in those who became diabetic before age 34 (22/24). In several individuals, 64KA were detected before the other autoantibodies appeared. These findings suggest that 64KA may be an early and useful predictive marker for IDD.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971659     DOI: 10.1016/0140-6736(90)91241-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  62 in total

Review 1.  Molecular mechanisms involved in the etiology and pathogenesis of autoimmune diseases.

Authors:  M Trucco
Journal:  Clin Investig       Date:  1992-09

2.  GAD65 antibody isotypes and epitope recognition during the prediabetic process in siblings of children with type I diabetes.

Authors:  S Hoppu; M S Ronkainen; P Kulmala; H K Akerblom; M Knip
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

3.  Autoantibodies to 64,000-M(r) islet cell protein in long-term type 1 (insulin-dependent) diabetic patients.

Authors:  E Kawasaki; R Moriuchi; H Takino; S Okuno; Y Takao; Y Maeda; A Yokota; H Yamamoto; N Chikuba; S Akazawa
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

Review 4.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

5.  IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.

Authors:  M S Lan; C Wasserfall; N K Maclaren; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

6.  Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.

Authors:  W Richter; Y Shi; S Baekkeskov
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

7.  Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.

Authors:  L Wen; F S Wong; L Burkly; M Altieri; C Mamalaki; D Kioussis; R A Flavell; R S Sherwin
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin.

Authors:  A C Griffin; W Zhao; K W Wegmann; W F Hickley
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

9.  Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.

Authors:  M A Atkinson; M A Bowman; L Campbell; B L Darrow; D L Kaufman; N K Maclaren
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Baclofen, a gamma-aminobutyric acid-b receptor agonist, delays diabetes onset in the non-obese diabetic mouse.

Authors:  P E Beales; M Hawa; A J Williams; M C Albertini; A Giorgini; P Pozzilli
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.